Xiangyu Medical (688626.SH) Announces 2023 Restricted Stock Incentive Plan

Sunnyou (688626.SH) announced its 2023 Restricted Stock Incentive Plan (Draft). This incentive plan proposes to grant a total of 1.8 million restricted shares, accounting for 1.1250% of the company's total share capital at the time of the announcement of this incentive plan draft. Among them, the number of restricted shares to be initially granted is 1.44 million, accounting for 0.90% of the company's total share capital at the time of the announcement of this incentive plan draft and 80% of the total proposed incentives under this plan; the number of reserved restricted shares is 360,000, accounting for 0.2250% of the company's total share capital at the time of the announcement of this incentive plan draft and 20% of the total proposed incentives under this plan.

The grant price of the restricted shares awarded to the incentivized individuals under this incentive plan is 32 yuan per share. The initial grant under this incentive plan covers 163 individuals, including directors, senior management, core technical personnel, and other individuals deemed by the board as requiring incentives, all of whom were employed by the company (including subsidiaries, hereinafter the same) at the time of the announcement of this incentive plan. The validity period of this incentive plan shall be from the date of the grant of the restricted shares until the date when all shares have either vested or become void, with a maximum duration of no more than 36 months.